Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 179 publications
New-Onset Heart Failure in Hemodialysis Patients: Association With Access Location and Access Flow in a Nationwide Cohort From Sweden.
Journal: Kidney medicine
Published: July 30, 2026
Author Correction: Treatment of liver cirrhosis using hepatocyte-derived liver progenitor-like cells: a prospective, open-label, single-arm, safety trial.
Journal: Cell discovery
Published: December 10, 2025
Treatment of liver failure utilizing multi-cell lineage liver microtissue.
Journal: JHEP reports : innovation in hepatology
Published: November 25, 2025
Response to letter regarding 'Patient-related factors influencing the choice of haemodialysis access in Sweden'.
Journal: The journal of vascular access
Published: October 08, 2025
Impaired glycoRNA biogenesis in metabolic-dysfunction associated steatotic liver disease.
Journal: Journal of hepatology
Published: September 18, 2025
[18F]FDG-PET provides insights into the liver-brain axis and confirms SUVgluc as a surrogate for MRGlu in a mouse model of liver fibrosis.
Journal: Nuclear medicine and biology
Published: July 28, 2025
Patient-related factors influencing the choice of haemodialysis access in Sweden.
Journal: The journal of vascular access
Published: July 23, 2025
In vivo base editing alleviates hepatic iron accumulation and fibrosis in models of HFE-related hereditary hemochromatosis.
Journal: Journal of hepatology
Published: July 15, 2025
In vivo base editing gene therapy for heterozygous familial hypercholesterolemia: a phase 1 trial.
Journal: Nature medicine
Published: May 20, 2025
AAV8-based gene replacement therapy for hereditary spastic paraplegia type 5.
Journal: Molecular therapy. Methods & clinical development
Published: May 16, 2025
Update of data from the world apheresis association (WAA) registry.
Journal: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis
Published: May 06, 2025
Preclinical evaluation of AGT mRNA replacement therapy for primary hyperoxaluria type I disease.
Journal: Science advances
Published: April 09, 2025
Last Updated: 09/26/2026